Breath ethane in dialysis patients and control subjects.
暂无分享,去创建一个
Claudio Ronco | George A Kaysen | Nathan W Levin | C. Ronco | N. Levin | R. Nicolosi | G. Kaysen | L. Rosales | N. Hoenich | G. Handelman | Nicholas A Hoenich | Garry J Handelman | Laura M Rosales | Damian Barbato | Jason Luscher | Rohini Adhikarla | Robert J Nicolosi | Frederic O Finkelstein | Damian Barbato | F. Finkelstein | R. Adhikarla | Jason Luscher
[1] C. Price,et al. Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. , 1987, Journal of immunological methods.
[2] J. Blumberg,et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. , 2001, Kidney international.
[3] V. Böhm,et al. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. , 1997, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[4] M. F. Weiss,et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. , 2000, Kidney international.
[5] F. Ursini,et al. Oxidant stress in hemodialysis: prevention and treatment strategies. , 2000, Kidney international. Supplement.
[6] I. West. Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[7] K. Iseki,et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] S. Banni,et al. No direct evidence of increased lipid peroxidation in hemodialysis patients. , 1996, Nephron.
[9] G. Handelman. Evaluation of Oxidant Stress in Dialysis Patients , 2000, Blood Purification.
[10] J. Belch,et al. Lipid Perxidtion and Antioxidants in Continuous Ambulatory Dialysis Patients , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[11] E. Lowrie,et al. Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] C U Casciani,et al. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. , 1984, Nephron.
[13] S. Khashan,et al. Red blood cell membrane lipid peroxidation in continuous ambulatory peritoneal dialysis patients. , 1986, American journal of nephrology.
[14] P. Jungers,et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.
[15] J. Himmelfarb,et al. Manifestations of Oxidant Stress in Uremia , 2000, Blood Purification.
[16] M D Knutson,et al. Methods for measuring ethane and pentane in expired air from rats and humans. , 2000, Free radical biology & medicine.
[17] W. Hörl,et al. Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate. , 1994, Clinical nephrology.
[18] M. Leichsenring,et al. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. , 1996, Kidney international.
[19] D. Betteridge,et al. Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM , 1995, Diabetes.
[20] J. Springfield,et al. Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. , 1994, Journal of lipid research.
[21] D. Betteridge,et al. Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus , 1995, FEBS letters.
[22] W. März,et al. Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis , 1999 .
[23] R. Abrams,et al. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study. , 1994, Free radical biology & medicine.
[24] G. Kaysen,et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] S. Walmsley,et al. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. , 1998, The American journal of clinical nutrition.
[26] F. Viteri,et al. A practical and reliable method for measuring ethane and pentane in expired air from humans. , 1999, Free radical biology & medicine.
[27] M. Mydlík,et al. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. , 1998, Artificial organs.
[28] M. Habib,et al. Ethane production rate in rats exposed to high oxygen concentration. , 1988, The American review of respiratory disease.
[29] H. Garewal,et al. Cigarette smoking and ethane exhalation in humans. , 1995, American journal of respiratory and critical care medicine.
[30] M. Boaz,et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.
[31] J. Roob,et al. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. , 2000, Journal of the American Society of Nephrology : JASN.
[32] J. Cristol,et al. Imbalance of Oxidants and Antioxidants in Haemodialysis Patients , 1999, Blood Purification.
[33] K.,et al. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. , 2001, Kidney international.
[34] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[35] N. Villamor,et al. Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques. , 1994, The Journal of laboratory and clinical medicine.
[36] T. Miyata,et al. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? , 1998, Kidney international.
[37] A. Sevanian,et al. Oxidative Cross-linking of ApoB100 and Hemoglobin Results in Low Density Lipoprotein Modification in Blood , 1999, The Journal of Biological Chemistry.
[38] N. Levin,et al. Oxidative stress and inflammation in hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] C. Kneepkens,et al. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.
[40] N Rifai,et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. , 2001, JAMA.
[41] Mario Timio,et al. Volatile Alkanes and Increased Concentrations of Isoprene in Exhaled Air during Hemodialysis , 1999, Nephron.
[42] J. B. Park,et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Cristol,et al. Why Hemodialysis Patients Are in a Prooxidant State? What Could Be Done to Correct the Pro/Antioxidant Imbalance , 2000, Blood Purification.
[44] A. Ceriello. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. , 1999, Diabetes, nutrition & metabolism.
[45] R. Lubrano,et al. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment. , 1994, ASAIO journal.
[46] J. Hegbrant,et al. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. , 1997, Clinical nephrology.
[47] T. Hannedouche,et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[48] K. Hensley,et al. Reactive oxygen species, cell signaling, and cell injury. , 2000, Free radical biology & medicine.
[49] B. Kestenbaum,et al. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. , 2002, Kidney international.
[50] J. Morrow,et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. , 2002, Clinical nephrology.